Down-regulation of granulocyte-macrophage colony-stimulating factor by 3C-like proteinase in transfected A549 human lung carcinoma cells

BMC Immunology

Volumn 12, Issue , 2011, Pages

  Liao, Hsien Hua ^a,b   Wang, Yao Chen ^a,b   Chen, Miles C ^c   Tsai, Hsien Yu ^c,d   Lin, Johnson ^c,e   Chen, Shui Tein ^c,d,f   Tsay, Gregory J ^a,b   Cheng, Sun Long ^b  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c INSTITUTE OF BIOLOGICAL CHEMISTRY   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^e UNIVERSITY OF KWAZULU NATAL   (South Africa)

^f GENOMICS RESEARCH CENTER   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12P40; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; PLASMID ENHANCED GREEN FLUORESCENT PROTEIN C3 VECTOR; PLASMID VECTOR; PROTEINASE; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; 3C LIKE PROTEASE, SARS CORONAVIRUS; 3C-LIKE PROTEASE, SARS CORONAVIRUS; CYSTEINE PROTEINASE; GREEN FLUORESCENT PROTEIN; TRANSFORMING GROWTH FACTOR BETA; VIRUS PROTEIN;

ARTICLE; CANCER CELL CULTURE; CELL NUCLEUS; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOPLASM; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENE LOCATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; LUNG CARCINOMA; ONCOGENE C MYC; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SARS CORONAVIRUS; FLUORESCENCE MICROSCOPY; GENETICS; LUNG TUMOR; METABOLISM; MUTATION; PATHOLOGY; TUMOR CELL LINE; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL LINE, TUMOR; CYSTEINE ENDOPEPTIDASES; DOWN-REGULATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; GREEN FLUORESCENT PROTEINS; HUMANS; INTERLEUKIN-12 SUBUNIT P40; INTERLEUKIN-1BETA; INTERLEUKIN-6; INTERLEUKIN-8; LUNG NEOPLASMS; MICROSCOPY, FLUORESCENCE; MUTATION; NF-KAPPA B; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA; VIRAL PROTEINS;

EID: 79951585715     PISSN: None     EISSN: 14712172     Source Type: Journal    
DOI: 10.1186/1471-2172-12-16     Document Type: Article

References (38)

1. Fouchier RA, Kuiken T, Schutten M, van Amerongen G, van Doornum GJ, van den Hoogen BG, Peiris M, Lim W, Stohr K, Osterhaus AD. Aetiology: Koch's postulates fulfilled for SARS virus. Nature 2003, 423:240. 10.1038/423240a, 12748632.
2. Rota PA, Oberste MS, Monroe SS, Nix WA, Campagnoli R, Icenogle JP, Penaranda S, Bankamp B, Maher K, Chen MH, et al. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 2003, 300:1394-9. 10.1126/science.1085952, 12730500.
3. Ksiazek TG, Erdman D, Goldsmith CS, Zaki SR, Peret T, Emery S, Tong S, Urbani C, Comer JA, Lim W, et al. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 2003, 348:1953-66. 10.1056/NEJMoa030781, 12690092.
4. Marra MA, Jones SJ, Astell CR, Holt RA, Brooks-Wilson A, Butterfield YS, Khattra J, Asano JK, Barber SA, Chan SY, et al. The Genome sequence of the SARS-associated coronavirus. Science 2003, 300:1399-404. 10.1126/science.1085953, 12730501.
5. Graham RL, Sparks JS, Eckerle LD, Sims AC, Denison MR. SARS coronavirus replicase proteins in pathogenesis. Virus Res 2008, 133:88-100. 10.1016/j.virusres.2007.02.017, 2637536, 17397959.
6. Prentice E, McAuliffe J, Lu X, Subbarao K, Denison MR. Identification and characterization of severe acute respiratory syndrome coronavirus replicase proteins. J Virol 2004, 78:9977-86. 10.1128/JVI.78.18.9977-9986.2004, 514967, 15331731.
7. Hsu MF, Kuo CJ, Chang KT, Chang HC, Chou CC, Ko TP, Shr HL, Chang GG, Wang AH, Liang PH. Mechanism of the maturation process of SARS-CoV 3CL protease. J Biol Chem 2005, 280:31257-66. 10.1074/jbc.M502577200, 15788388.
8. Sun H, Luo H, Yu C, Sun T, Chen J, Peng S, Qin J, Shen J, Yang Y, Xie Y, et al. Molecular cloning, expression, purification, and mass spectrometric characterization of 3C-like protease of SARS coronavirus. Protein Expr Purif 2003, 32:302-8. 10.1016/j.pep.2003.08.016, 14965777.
9. Fan K, Wei P, Feng Q, Chen S, Huang C, Ma L, Lai B, Pei J, Liu Y, Chen J, et al. Biosynthesis, purification, and substrate specificity of severe acute respiratory syndrome coronavirus 3C-like proteinase. J Biol Chem 2004, 279:1637-42. 10.1074/jbc.M310875200, 14561748.
10. Anand K, Ziebuhr J, Wadhwani P, Mesters JR, Hilgenfeld R. Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs. Science 2003, 300:1763-7. 10.1126/science.1085658, 12746549.
11. Huang C, Wei P, Fan K, Liu Y, Lai L. 3C-like proteinase from SARS coronavirus catalyzes substrate hydrolysis by a general base mechanism. Biochemistry 2004, 43:4568-74. 10.1021/bi036022q, 15078103.
12. Lin CW, Lin KH, Hsieh TH, Shiu SY, Li JY. Severe acute respiratory syndrome coronavirus 3C-like protease-induced apoptosis. FEMS Immunol Med Microbiol 2006, 46:375-80. 10.1111/j.1574-695X.2006.00045.x, 16553810.
13. Lin CW, Tsai FJ, Wan L, Lai CC, Lin KH, Hsieh TH, Shiu SY, Li JY. Binding interaction of SARS coronavirus 3CL(pro) protease with vacuolar-H+ ATPase G1 subunit. FEBS Lett 2005, 579:6089-94. 10.1016/j.febslet.2005.09.075, 16226257.
14. Kiemer L, Lund O, Brunak S, Blom N. Coronavirus 3CLpro proteinase cleavage sites: possible relevance to SARS virus pathology. BMC Bioinformatics 2004, 5:72. 10.1186/1471-2105-5-72, 15180906.
15. Nicholls JM, Poon LL, Lee KC, Ng WF, Lai ST, Leung CY, Chu CM, Hui PK, Mak KL, Lim W, et al. Lung pathology of fatal severe acute respiratory syndrome. Lancet 2003, 361:1773-8. 10.1016/S0140-6736(03)13413-7, 12781536.
16. Wang CH, Liu CY, Wan YL, Chou CL, Huang KH, Lin HC, Lin SM, Lin TY, Chung KF, Kuo HP. Persistence of lung inflammation and lung cytokines with high-resolution CT abnormalities during recovery from SARS. Respir Res 2005, 6:42. 10.1186/1465-9921-6-42, 1156954, 15888207.
17. Lo AW, Tang NL, To KF. How the SARS coronavirus causes disease: host or organism?. J Pathol 2006, 208:142-51. 10.1002/path.1897, 16362992.
18. Wong CK, Lam CW, Wu AK, Ip WK, Lee NL, Chan IH, Lit LC, Hui DS, Chan MH, Chung SS, et al. Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome. Clin Exp Immunol 2004, 136:95-103. 10.1111/j.1365-2249.2004.02415.x, 1808997, 15030519.
19. Zhu M. SARS Immunity and Vaccination. Cell Mol Immunol 2004, 1:193-8.
20. Xu X, Gao X. Immunological responses against SARS-coronavirus infection in humans. Cell Mol Immunol 2004, 1:119-22.
21. Cheung CY, Poon LL, Ng IH, Luk W, Sia SF, Wu MH, Chan KH, Yuen KY, Gordon S, Guan Y, et al. Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis. J Virol 2005, 79:7819-26. 10.1128/JVI.79.12.7819-7826.2005, 1143636, 15919935.
22. Jiang Y, Xu J, Zhou C, Wu Z, Zhong S, Liu J, Luo W, Chen T, Qin Q, Deng P. Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome. Am J Respir Crit Care Med 2005, 171:850-7. 10.1164/rccm.200407-857OC, 15657466.
23. Lin YS, Lin CF, Fang YT, Kuo YM, Liao PC, Yeh TM, Hwa KY, Shieh CC, Yen JH, Wang HJ, et al. Antibody to severe acute respiratory syndrome (SARS)-associated coronavirus spike protein domain 2 cross-reacts with lung epithelial cells and causes cytotoxicity. Clin Exp Immunol 2005, 141:500-8. 10.1111/j.1365-2249.2005.02864.x, 1809466, 16045740.
24. Yang YH, Huang YH, Chuang YH, Peng CM, Wang LC, Lin YT, Chiang BL. Autoantibodies against human epithelial cells and endothelial cells after severe acute respiratory syndrome (SARS)-associated coronavirus infection. J Med Virol 2005, 77:1-7. 10.1002/jmv.20407, 16032747.
25. Griego SD, Weston CB, Adams JL, Tal-Singer R, Dillon SB. Role of p38 mitogen-activated protein kinase in rhinovirus-induced cytokine production by bronchial epithelial cells. J Immunol 2000, 165:5211-20.
26. Munoz C, Pascual-Salcedo D, Castellanos MC, Alfranca A, Aragones J, Vara A, Redondo JM, de Landazuri MO. Pyrrolidine dithiocarbamate inhibits the production of interleukin-6, interleukin-8, and granulocyte-macrophage colony-stimulating factor by human endothelial cells in response to inflammatory mediators: modulation of NF-kappa B and AP-1 transcription factors activity. Blood 1996, 88:3482-90.
27. Ziegler T, Matikainen S, Ronkko E, Osterlund P, Sillanpaa M, Siren J, Fagerlund R, Immonen M, Melen K, Julkunen I. Severe acute respiratory syndrome coronavirus fails to activate cytokine-mediated innate immune responses in cultured human monocyte-derived dendritic cells. J Virol 2005, 79:13800-5. 10.1128/JVI.79.21.13800-13805.2005, 1262618, 16227300.
28. Woltman AM, van der Kooij SW, Coffer PJ, Offringa R, Daha MR, van Kooten C. Rapamycin specifically interferes with GM-CSF signaling in human dendritic cells, leading to apoptosis via increased p27KIP1 expression. Blood 2003, 101:1439-45. 10.1182/blood-2002-06-1688, 12393532.
29. Eager R, Nemunaitis J. GM-CSF gene-transduced tumor vaccines. Mol Ther 2005, 12:18-27. 10.1016/j.ymthe.2005.02.012, 15963916.
30. LeVine AM, Reed JA, Kurak KE, Cianciolo E, Whitsett JA. GM-CSF-deficient mice are susceptible to pulmonary group B streptococcal infection. J Clin Invest 1999, 103:563-9. 10.1172/JCI5212, 408099, 10021465.
31. Trapnell BC, Whitsett JA. Gm-CSF regulates pulmonary surfactant homeostasis and alveolar macrophage-mediated innate host defense. Annu Rev Physiol 2002, 64:775-802. 10.1146/annurev.physiol.64.090601.113847, 11826288.
32. Moore BB, Coffey MJ, Christensen P, Sitterding S, Ngan R, Wilke CA, McDonald R, Phare SM, Peters-Golden M, Paine R, et al. GM-CSF regulates bleomycin-induced pulmonary fibrosis via a prostaglandin-dependent mechanism. J Immunol 2000, 165:4032-9.
33. Christensen PJ, Bailie MB, Goodman RE, O'Brien AD, Toews GB, Paine R. Role of diminished epithelial GM-CSF in the pathogenesis of bleomycin-induced pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 2000, 279:L487-95.
34. Trapnell BC, Whitsett JA, Nakata K. Pulmonary alveolar proteinosis. N Engl J Med 2003, 349:2527-39. 10.1056/NEJMra023226, 14695413.
35. Kiemer L, Lund O, Brunak S, Blom N. Coronavirus 3CLpro proteinase cleavage sites: Possible relevance to SARS virus pathology. BMC Bioinformatics 2004, 5:72. 10.1186/1471-2105-5-72, 442122, 15180906.
36. Hegyi A, Ziebuhr J. Conservation of substrate specificities among coronavirus main proteases. J Gen Virol 2002, 83:595-599.
37. Hideshi N, Yoshiki U, Makoto K, Ryoji H, Hirokuni T. Cyclooxygenase-2 inhibitor NS-398 suppresses cell growth and constitutive production of granulocyte-colony stimulating factor and granulocyte macrophage-colony stimulating factor in lung cancer cells. Cancer Science 2003, 94:173-180. 10.1111/j.1349-7006.2003.tb01415.x, 12708493.
38. Hongsachart P, Huang-Liu R, Sinchaikul S, Pan FM, Phutrakul S, Chuang YM, Yu CJ, Chen ST. Glycoproteomic analysis of WGA-bound glycoprotein biomarkers in sera from patients with lung adenocarcinoma. Electrophoresis 2009, 30:1206-20. 10.1002/elps.200800405, 19294700.